A Phase IV, Open-Label Study of Tysabri (Natalizumab) in Patients Who Failed Anti-TNF-A Therapy

  • De Villiers, Willem (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date1/1/09 → 8/31/09